Asuragen Scientific Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Rapid, Equitable Molecular Confirmation of Pathogenic Variants in the CFTR Gene for Cystic Fibrosis Testing with Dried Blood Spots
Kevin Kelnar , Sarah Edelmon, Steven Partin, Elliot Hallmark, Connor Parker, John Hedges, John N. Milligan
Molecular Controls for SARS-CoV-2 and Influenza A/B Testing in Microchip-based RT-PCR Test Systems
Sikander Gill, Rajwant Gill, Natallia Varankovich, Irina Gelimson, Chandanee Dancey, Kelly Jackson, Steven Bailey, Emoni Robinson, Frank Hui, Andre Brown, Richard Elliott, Maxim Slyadnev, and Deepa Eveleigh
Back To